Literature DB >> 17219365

IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells.

Alice E Denton1, Peter C Doherty, Stephen J Turner, Nicole L La Gruta.   

Abstract

The potent innate cytokines IL-12 and IL-18 are considered to be important antigen-independent mediators of IFN-gamma production by NK cells and T lymphocytes. The present analysis addresses the physiological role of IL-12 and IL-18 in the generation of virus-specific CD8+ T cells. Both wt C57BL/6J (B6) mice and mice with disrupted IL-12p40 (IL-12p40(-/-)) or IL-18 (IL-18(-/-)) genes were infected with an influenza A virus and the characteristics of the resultant epitope-specific CD8+ T cell responses were compared. While IL-12 appeared to have no notable effect on either virus growth or on CD8+ T cell response profiles, the absence of IL-18 was associated with delayed virus clearance from the lung and, despite normal numbers, a significantly reduced production of IFN-gamma, TNF-alpha, and IL-2 by epitope-specific CD8+ T cells. While this cytokine phenotype was broadly maintained in IL-12p40/IL-18 double-knockout mice, no evidence was seen for any additive effect. Together, our results suggest that IL-18, but not IL-12, induces optimal, antigen-specific production of key cytokines by CD8+ T cells for the efficient clearance of influenza virus from the lungs of infected mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219365     DOI: 10.1002/eji.200636766

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

Review 1.  Migration, maintenance and recall of memory T cells in peripheral tissues.

Authors:  David L Woodland; Jacob E Kohlmeier
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

Review 2.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

3.  Cytokine protein expression levels in tracheobronchial lymph node homogenates of pigs infected with pseudorabies virus.

Authors:  Laura C Miller; Eraldo L Zanella; W Ray Waters; Kelly M Lager
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

4.  Pyroptosis in Antiviral Immunity.

Authors:  Teneema Kuriakose; Thirumala-Devi Kanneganti
Journal:  Curr Top Microbiol Immunol       Date:  2019-12-25       Impact factor: 4.291

5.  Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.

Authors:  Jessica M Breslow-Deckman; Cynthia M Mattingly; Susan E Birket; Samantha N Hoskins; Tam N Ho; Beth A Garvy; David J Feola
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

6.  The role of MyD88 signaling in heterosubtypic influenza A virus infections.

Authors:  Rachel F Madera; Daniel H Libraty
Journal:  Virus Res       Date:  2012-12-10       Impact factor: 3.303

7.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

8.  A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet.

Authors:  Annie Xin; Frederick Masson; Yang Liao; Simon Preston; Tianxia Guan; Renee Gloury; Moshe Olshansky; Jian-Xin Lin; Peng Li; Terence P Speed; Gordon K Smyth; Matthias Ernst; Warren J Leonard; Marc Pellegrini; Susan M Kaech; Stephen L Nutt; Wei Shi; Gabrielle T Belz; Axel Kallies
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

9.  Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis.

Authors:  Mitsuru Tsuge; Takashi Oka; Nobuko Yamashita; Yukie Saito; Yosuke Fujii; Yoshiharu Nagaoka; Masato Yashiro; Hirokazu Tsukahara; Tsuneo Morishima
Journal:  J Neurovirol       Date:  2014-01-24       Impact factor: 2.643

10.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.